| Literature DB >> 23171900 |
Anne Desjardins1, Hélène Coignard-Biehler, Nizar Mahlaoui, Pierre Frange, Marie-Elisabeth Bougnoux, Stéphane Blanche, Alain Fischer, Sophie Blumental, Olivier Lortholary.
Abstract
Chronic granulomatous disease is a genetic disorder responsible for a defect in the NADPH oxidase of phagocytic cells. It impairs the oxidative burst necessary to the intracellular inactivation of microorganisms and predisposes to an increased risk of infections by various microorganisms, including fungi like Aspergillus spp. and other less frequently encountered or emerging fungal species. Here we review the genetic basis, pathogenesis and clinical presentation associated with fungal infections in chronic granulomatous disease as well as the current prophylaxis and newly available therapies.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23171900 DOI: 10.1051/medsci/20122811015
Source DB: PubMed Journal: Med Sci (Paris) ISSN: 0767-0974 Impact factor: 0.818